๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
1812 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
NCT06786338IgA Nephropathy (IgAN), C3 Glomerulopathy, IC-MPGN
Suzhou Sanegene Bio Inc.
Phase 2
45
Beijing, Changsha, Chengdu, Guiyang, Hangzhou, Shanghai, Yangzhou, Yinchuan
2025-06-06
Recruiting
Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
NCT06947291Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2
350
Hangzhou
2025-06-04
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222Leukemia, Myeloid, Acute
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Jinan
2025-06-04
Recruiting
Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases
NCT07008287Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Observational
100
Hangzhou
2025-06-04
Recruiting
Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis
NCT07271576Liver Fibrosis, Liver Cirrhosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-06-04
Recruiting
Study of ESG406 in Adults With Solid Tumors
NCT06979674Locally Advanced/Metastatic Solid Tumors
Shanghai Escugen Biotechnology Co., Ltd
Phase 1
556
Chongqing, Xiโ€™an, Hangzhou
2025-06-04
Recruiting
Omitting CTV for Primary Tumor in LS-SCLC
NCT07008716SCLC, Limited Stage, Radiation Exposure, Radiotherapy Side Effect, Progression
Sun Yat-sen University
Phase 3
852
Guangzhou, Hangzhou
2025-06-03
Recruiting
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
NCT06958536Crohn's Disease
Sanofi
Phase 2
99
Changsha, Changzhou, Guangzhou, Hangzhou, Nanchang, Shanghai, Shenyang
2025-06-03
Recruiting
PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery
NCT06952387Hypotension
Nanfang Hospital, Southern Medical University
Not applicable
1,624
Guangzhou, Shenzhen, Zhuhai, Xiโ€™an, Hangzhou
2025-06-03
Recruiting
AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease
NCT06858553Crohn Disease (CD)
Minhu Chen
Observational
234
Guangzhou, Nanjing, Huangpu, Hangzhou
2025-06-03
Recruiting
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
NCT07293325Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
66
Hangzhou
2025-06-02
Recruiting
Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
NCT06979271Telitacicept, Treatment Compliance, Rheumatoid Arthritis
Zhejiang Provincial People's Hospital
Observational
20
Hangzhou
2025-06-01
Not yet open
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
NCT06939400Glioblastoma Multiforme (GBM)
Zhejiang Provincial People's Hospital
Observational
100
Hangzhou
2025-06-01
Recruiting
Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta
NCT07092358Hereditary Ataxia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,000
Hangzhou, Shanghai
2025-06-01
Active, closed
The R-E-V-I-V-A-L Study
NCT06992674Vestibular Migraine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
240
Hangzhou
2025-06-01
Not yet open
LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss
NCT06999278Abortion, Habitual
Women's Hospital School Of Medicine Zhejiang University
Phase 3
200
Hangzhou
2025-06-01
Recruiting
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
NCT07025174Bile Duct Carcinoma, Gall Bladder Cancer, Biliary Tract Cancer, Cholangiocarcinoma
First Affiliated Hospital of Zhejiang University
Phase 2
60
Hangzhou
2025-06-01
Recruiting
Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study
NCT06996665Respiratory Failure
Sir Run Run Shaw Hospital
Not applicable
100
Hangzhou
2025-06-01
Not yet open
Auricular Acupressure for Perimenopausal Insomnia
NCT06856421Perimenopausal Insomnia
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
160
Hangzhou
2025-06-01
Recruiting
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
NCT07321626Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Delayed Platelet Engraftment, HSCT
First Affiliated Hospital of Zhejiang University
Phase 1
130
Hangzhou
2025-06-01
Active, closed
Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia
NCT07199855B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University
Phase 2
24
Hangzhou
2025-06-01
Recruiting
Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion
NCT07016854Stroke, Acute Ischemic
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2025-06
Recruiting
Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction
NCT06742125ST-elevation Myocardial Infarction (STEMI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,244
Hangzhou
2025-05-31
Recruiting
Clinical Evaluation of GRAPE Model for Gastric Cancer Screening
NCT07067983Gastric Cancer
Zhejiang Cancer Hospital
Observational
1,000,000
Hangzhou
2025-05-30
Not yet open
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
NCT06963502Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
762
Hangzhou, Shanghai
2025-05-30
Recruiting
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
NCT07006077Advanced Pancreatic Cancer
Hangzhou Converd Co., Ltd.
Phase 2
12
Hangzhou
2025-05-29
Recruiting
In Vivo Study on the Material Properties of iRoot SP and nRoot SP Root Canal Sealers
NCT07388901Chronic Apical Periodontitis
The Dental Hospital of Zhejiang University School of Medicine
Not applicable
160
Hangzhou
2025-05-27
Active, closed
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
NCT07032597Mid Face Volume Deficit
AbbVie
Phase 3
252
Beijing, Wuhan, Nanjing, Wuxi, Shanghai, Hangzhou
2025-05-26
Active, closed
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT07035041UC - Ulcerative Colitis, Moderately to Severely Active Ulcerative Colitis
InventisBio Co., Ltd
Phase 2
120
Hangzhou
2025-05-22
By invitation
The Efficacy and Safety of IBI351, Cetuximab ฮฒ Combined With FOLFIRI as First-line /IBI351, Cetuximab ฮฒ as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
NCT06959589Colorectal Cancer Metastatic, KRAS G12C Mutation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
50
Hangzhou
2025-05-22
Recruiting
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
NCT07034339Immune Evasion, Tumor, Pancreas Cancer
First Affiliated Hospital of Zhejiang University
Observational
1,500
Hangzhou
2025-05-21
Not yet open
Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
NCT06964971Transfusion-dependent Non-severe Aplastic Anemia
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
90
Hangzhou
2025-05-20
Recruiting
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
NCT07021508Bipolar Depression
First Affiliated Hospital of Zhejiang University
Not applicable
160
Hangzhou
2025-05-20
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
NCT06830798Delayed Graft Function, DGF, Kidney Transplant
Alexion Pharmaceuticals, Inc.
Phase 3
450
Guangzhou, Hangzhou, Hengyang, Nanning, Shenzhen, Taiyuan, Tianjin, Zhengzhou
2025-05-19
Recruiting
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
NCT07033234Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
142
Hangzhou
2025-05-16
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993Atopic Dermatitis
Novartis Pharmaceuticals
Phase 2
224
Guangzhou, Shantou, Changsha, Changchun, Hangzhou, Beijing, Shanghai
2025-05-16
Recruiting
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
NCT06883526Lymphoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
60
Hangzhou
2025-05-16
Not yet open
Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease
NCT06821529Parkinson Disease
iCamuno Biotherapeutics Ltd.
Phase 1
12
Hangzhou
2025-05-15
Recruiting
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
NCT06926283Prostate Cancer, Other Solid Tumors, Ewing Sarcoma
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Changsha, Hangzhou, Beijing
2025-05-15
Recruiting
Comparison of Sequential to Initial Combination Therapy in PAH
NCT06968962Pulmonary Arterial Hypertension (PAH)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
376
Hangzhou
2025-05-14
Recruiting
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
NCT06912152B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University
Phase 1
12
Hangzhou
2025-05-12
Recruiting
Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
NCT06972576Non-Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
18
Hangzhou
2025-05-09
Recruiting
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
NCT07038720Plaque Psoriasis, Healthy Volunteer
Usynova Pharmaceuticals Ltd.
Phase 1
124
Hangzhou
2025-05-08
Active, closed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT06799286Small Cell Lung Carcinoma
Bristol-Myers Squibb
Phase 1
10
Beijing, Jinan, Linyi, Hangzhou, Shanghai
2025-05-07
Not yet open
A Clinical Study of AK139 in Healthy Subjects
NCT06947109Healthy Subjects
Akeso
Phase 1
48
Hangzhou
2025-05-06
Recruiting
Effect of Video Viewing on Intravitreal Injection Experience
NCT07002372Age Related Macular Degeneration, Diabetic Retinopathy, Choroidal Neovascularization, Retinal Vein Occlusion
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
182
Hangzhou
2025-05-05
Recruiting
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
NCT07078500Diffuse Large B-Cell Lymphoma (DLBCL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
48
Hangzhou
2025-05-05
Recruiting
Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
NCT06874933HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
35
Hangzhou
2025-05-04
Not yet open
Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma
NCT06918015BTK Inhibitors, Follicular Lymphoma, Immunochemotherapy
Zhejiang Cancer Hospital
Phase 2
58
Hangzhou
2025-05-01
Not yet open
Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study
NCT06924645Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting), Extrapulmonary Neuroendocrine Neoplasms
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
40
Hangzhou
2025-05-01
Recruiting
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
NCT06939712Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou
2025-05-01
Not yet open
Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
NCT06960122Pancreatic Cancer, Resected, Diarrhea
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-05-01
Recruiting
Bevacizumab in the Treatment of HHT
NCT07828015Bevacizimab, HHT
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
40
Hangzhou
2025-05-01
Not yet open
Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors
NCT06932094Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1
256
Hangzhou
2025-05
Recruiting
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
NCT07692750Advanced Pancreatic Cancer
Zhejiang Cancer Hospital
Phase 1/2
56
Hangzhou
2025-04-30
Recruiting
A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
NCT06755671Indigestion, Dyspepsia, Bloating, Loss of Appetite
Shanghai Hutchison Pharmaceuticals Limited
Observational
4,500
Hangzhou
2025-04-30
Recruiting
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
NCT06934447CAR T Cell Therapy, Systemic Lupus Erythematosus, BCMA
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
18
Hangzhou
2025-04-25
Recruiting
A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
NCT06922357Advanced/Metastatic Solid Tumors
Shandong Suncadia Medicine Co., Ltd.
Phase 1/2
120
Harbin, Hangzhou
2025-04-24
Recruiting
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545Coronary Artery Disease, CT Angiography, PCSK9, Cardiovascular Events
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
3,596
Hangzhou, Jinhua
2025-04-22
Active, closed
Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
NCT07024212MASLD
Zhejiang Doer Biologics Co., Ltd.
Phase 2
110
Hangzhou, Changchun, Nanjing
2025-04-22
Recruiting
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
NCT06902896Dilated Cardiomyopathy (DCM), Heart Failure
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
43
Hangzhou
2025-04-22
Not yet open
Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
NCT06922916COPD, Interstitial Pneumonia, Bronchiectasis, Respiratory Failure
Zhejiang University
Observational
250
Hangzhou
2025-04-22
By invitation
Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab
NCT06719921Atrial Fibrillation (AF)
Sir Run Run Shaw Hospital
Not applicable
724
Hangzhou
2025-04-22
Recruiting
NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial
NCT07077551NENS
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
28
Hangzhou
2025-04-22
Recruiting
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
NCT06850103Colorectal Carcinoma, Oligometastases, pMMR, MSS
First Affiliated Hospital of Zhejiang University
Phase 2
51
Hangzhou
2025-04-22
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
National University of Singapore
Phase 4
600
Hangzhou, Xi'an, Xuzhou
2025-04-21
By invitation
VISOR Versus PCNL for Treatment of 2-4cm Renal Stones
NCT07159503Kidney Calculi, Kidney Stones
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
170
Hangzhou
2025-04-20
Recruiting
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
NCT06770439Advanced Pancreatic Cancers
Zhejiang University
Phase 2
64
Hangzhou
2025-04-18
Active, closed
Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
NCT06833723Breast Neoplasms
Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
Observational
1,000
Hangzhou
2025-04-17
Not yet open
9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors
NCT06926998Gynecological Malignancies
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
260
Hangzhou
2025-04-15
Active, closed
Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal Hemoglobinuria
NCT06848296Paroxysmal Nocturnal Hemoglobinuria (PNH)
Bisirna Therapeutics Pte. Ltd.
Phase 1
50
Beijing, Hangzhou
2025-04-15
Recruiting
Evaluation of the Efficacy of Electroacupuncture in the Treatment of Functional Dyspepsia
NCT06618911Functional Dyspepsia
Yi Liang
Not applicable
180
Hangzhou
2025-04-13
Recruiting
Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke
NCT06863571Ischemic Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
68
Hangzhou
2025-04-12
Recruiting
COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical Trial
NCT06796764Hypoxia, Esophageal Cancer, Gastric Cancer
Zhejiang University
Not applicable
580
Hangzhou
2025-04-11
Active, closed
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
NCT06866574Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia, Penile/Perianal/Perineal Cancer, Anal Cancer
Xiamen University
Phase 3
9,300
Fuzhou, Chengdu, Kunming, Hangzhou
2025-04-11
Recruiting
The Treatment of Moderate to Severe Allergic Rhinitis With Electroacupuncture Combined With Microneedle Knife
NCT06890260Allergic Rhinitis (Disorder), Electroacupuncture, Microneedle Knife
Pengfei Qiu
Not applicable
90
Hangzhou
2025-04-11
Recruiting
Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (โ… ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
NCT06888050New-onset Type 2 Diabetes
Zhejiang Provincial People's Hospital
Phase 4
268
Hangzhou
2025-04-11
Recruiting
Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors
NCT06952608Intraoperative Hypotension, Ciprofol, Renin-angiotensin System Inhibitors
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
140
Hangzhou
2025-04-10
Recruiting
Silkworm Pupa Powder Improves Dementia.
NCT06898476Alzheimer Disease(AD), Sarcopenia, Asthenia
Zhejiang Provincial Tongde Hospital
Not applicable
300
Hangzhou
2025-04-10
Recruiting
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
NCT06956716Advanced Intrahepatic Cholangiocarcinoma
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-09
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06790693Breast Cancer
Hoffmann-La Roche
Phase 3
450
Xiangyang, Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jiangmen
2025-04-09
Recruiting
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
NCT06995105Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-09
Recruiting
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
NCT06946615Colorectal Neoplasia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
18
Hangzhou
2025-04-08
Recruiting
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
NCT06920433Systemic Lupus Erythematosus
Zhejiang University
Phase EARLY_PHASE1
18
Hangzhou
2025-04-08
Recruiting
Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients
NCT07162298Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
72
Hangzhou
2025-04-07
Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
NCT06801834Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences
Phase 3
695
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-04-04
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
Recruiting
An Engineered Sirpฮฑ Fused to Anti-Pd-L1 And Tgf-ฮฒ Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
NCT06487624Advanced Solid Tumor, Refractory Hodgkin Lymphoma
FBD Biologics Limited
Phase 1
50
Hangzhou, Xuzhou, Yantai, Zhujiang
2025-04-02
Not yet open
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
NCT06888674Pancreatic Cancer Resectable
Zhejiang University
Phase 1/2
60
Hangzhou
2025-04-01
Not yet open
Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer
NCT06872606Rectal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
33
Hangzhou
2025-04-01
Active, closed
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
NCT06992024Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-04-01
Recruiting
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
NCT06992648Colorectal Cancer Metastatic, Colorectal Cancer Recurrent
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
302
Hangzhou
2025-04-01
Not yet open
Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.
NCT06888648Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan
2025-04-01
Recruiting
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma
NCT06825546Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
70
Guangzhou, Zhengzhou, Wuhan, Changsha, Hangzhou, Wenzhou
2025-04-01
Recruiting
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
NCT07193654Glioblastoma (GBM)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Hangzhou
2025-04-01
Not yet open
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
NCT06933563Myasthenia Gravis
Zhejiang University
Phase EARLY_PHASE1
18
Hangzhou
2025-04
Not yet open
Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases
NCT06861218Leptomeningeal Metastases
Zhejiang Cancer Hospital
Phase 2
42
Hangzhou
2025-04
Recruiting
A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer
NCT06890858Ovarian Cancer
Zhejiang Provincial People's Hospital
Phase 2
20
Hangzhou
2025-04
Active, closed
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
NCT06921486Obesity and Overweight
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 2/3
1,003
Beijing, Changzhou, Chengdu, Guangzhou, Guangzhusi, Guizhou, Hangzhou, Harbin
2025-03-31
Rows per page Showing 701–800 of 1812
Previous 6 7 8 9 10 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou?page=8

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.